Lingua: Inglese
Editore: Cambridge University Press, 2010
ISBN 10: 0521760585 ISBN 13: 9780521760584
Da: Cronus Books, Carson City, NV, U.S.A.
Hardcover. Condizione: New. * NEW Inside and Out! Clean & Crisp Pages. (E-mail for more info./pics).
Lingua: Inglese
Editore: Cambridge University Press, 2010
ISBN 10: 0521760585 ISBN 13: 9780521760584
Da: Better World Books, Mishawaka, IN, U.S.A.
Prima edizione
Condizione: Very Good. 1st Edition. Pages intact with possible writing/highlighting. Binding strong with minor wear. Dust jackets/supplements may not be included. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good.
Lingua: Inglese
Editore: Cambridge University Press, 2010
ISBN 10: 0521760585 ISBN 13: 9780521760584
Da: ThriftBooks-Atlanta, AUSTELL, GA, U.S.A.
Hardcover. Condizione: As New. No Jacket. Pages are clean and are not marred by notes or folds of any kind. ~ ThriftBooks: Read More, Spend Less.
Lingua: Inglese
Editore: Cambridge University Press, 2010
ISBN 10: 0521760585 ISBN 13: 9780521760584
Da: WorldofBooks, Goring-By-Sea, WS, Regno Unito
EUR 9,66
Quantità: 1 disponibili
Aggiungi al carrelloHardback. Condizione: Very Good. The book has been read, but is in excellent condition. Pages are intact and not marred by notes or highlighting. The spine remains undamaged.
EUR 16,44
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: very good. Gut/Very good: Buch bzw. Schutzumschlag mit wenigen Gebrauchsspuren an Einband, Schutzumschlag oder Seiten. / Describes a book or dust jacket that does show some signs of wear on either the binding, dust jacket or pages.
EUR 154,01
Quantità: 3 disponibili
Aggiungi al carrelloCondizione: New.
EUR 157,50
Quantità: 2 disponibili
Aggiungi al carrelloPaperback. Condizione: Brand New. 250 pages. 9.25x7.50x9.25 inches. In Stock.
Condizione: New.
Lingua: Inglese
Editore: Cambridge University Press, 2010
ISBN 10: 0521760585 ISBN 13: 9780521760584
Da: California Books, Miami, FL, U.S.A.
EUR 177,83
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
Lingua: Inglese
Editore: Cambridge University Press, 2010
ISBN 10: 0521760585 ISBN 13: 9780521760584
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 163,16
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
Lingua: Inglese
Editore: Elsevier Science Publishing Co Inc, 2025
ISBN 10: 0443274126 ISBN 13: 9780443274121
Da: THE SAINT BOOKSTORE, Southport, Regno Unito
EUR 171,59
Quantità: Più di 20 disponibili
Aggiungi al carrelloPaperback / softback. Condizione: New. New copy - Usually dispatched within 4 working days.
EUR 175,46
Quantità: 3 disponibili
Aggiungi al carrelloCondizione: New.
Lingua: Inglese
Editore: Cambridge University Press, 2010
ISBN 10: 0521760585 ISBN 13: 9780521760584
Da: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irlanda
EUR 183,48
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. The future of mood-disorder research: covering identification of new therapeutic targets, preclinical models, and medicinal chemistry opportunities. Editor(s): Beyer, Chad E.; Stahl, Stephen M. Num Pages: 150 pages, 27 b/w illus. 10 tables. BIC Classification: MMGW. Category: (P) Professional & Vocational. Dimension: 242 x 156 x 62. Weight in Grams: 454. . 2010. New. hardcover. . . . .
Lingua: Inglese
Editore: Cambridge University Press, GB, 2010
ISBN 10: 0521760585 ISBN 13: 9780521760584
Da: Rarewaves.com USA, London, LONDO, Regno Unito
EUR 202,31
Quantità: Più di 20 disponibili
Aggiungi al carrelloHardback. Condizione: New. The World Health Organization defines depression as a primary contributor to the global burden of disease and predicts it will become the second leading cause of death by 2020. The need to develop effective therapies has never been so pressing. Current antidepressant drugs have several limitations. This 2010 book looks at the future of mood-disorder research, covering the identification of new therapeutic targets, establishing new preclinical models, new medicinal chemistry opportunities, and fostering greater understanding of genetic influences. These strategies are likely to help build a better picture of the disease process, and lead to new opportunities for patient stratification and treatment. The ultimate goal for this strand of research is to develop more personalized and effective treatments for this chronic and debilitating condition. This is essential reading for all those involved in psychopharmacologic drug development, and mental health clinicians seeking a preview of discoveries soon to influence their practice.
EUR 207,03
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
EUR 203,30
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
Lingua: Inglese
Editore: Cambridge University Press CUP, 2010
ISBN 10: 0521760585 ISBN 13: 9780521760584
Da: Books Puddle, New York, NY, U.S.A.
Condizione: New. pp. 150.
EUR 227,88
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
Lingua: Inglese
Editore: Cambridge University Press, 2010
ISBN 10: 0521760585 ISBN 13: 9780521760584
Da: Kennys Bookstore, Olney, MD, U.S.A.
EUR 229,86
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. The future of mood-disorder research: covering identification of new therapeutic targets, preclinical models, and medicinal chemistry opportunities. Editor(s): Beyer, Chad E.; Stahl, Stephen M. Num Pages: 150 pages, 27 b/w illus. 10 tables. BIC Classification: MMGW. Category: (P) Professional & Vocational. Dimension: 242 x 156 x 62. Weight in Grams: 454. . 2010. New. hardcover. . . . . Books ship from the US and Ireland.
EUR 228,59
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
Lingua: Inglese
Editore: Cambridge University Press, GB, 2010
ISBN 10: 0521760585 ISBN 13: 9780521760584
Da: Rarewaves.com UK, London, Regno Unito
EUR 192,54
Quantità: Più di 20 disponibili
Aggiungi al carrelloHardback. Condizione: New. The World Health Organization defines depression as a primary contributor to the global burden of disease and predicts it will become the second leading cause of death by 2020. The need to develop effective therapies has never been so pressing. Current antidepressant drugs have several limitations. This 2010 book looks at the future of mood-disorder research, covering the identification of new therapeutic targets, establishing new preclinical models, new medicinal chemistry opportunities, and fostering greater understanding of genetic influences. These strategies are likely to help build a better picture of the disease process, and lead to new opportunities for patient stratification and treatment. The ultimate goal for this strand of research is to develop more personalized and effective treatments for this chronic and debilitating condition. This is essential reading for all those involved in psychopharmacologic drug development, and mental health clinicians seeking a preview of discoveries soon to influence their practice.
Lingua: Inglese
Editore: Cambridge University Press, 2010
ISBN 10: 0521760585 ISBN 13: 9780521760584
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 208,43
Quantità: 1 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - The World Health Organization defines depression as a primary contributor to the global burden of disease and predicts it will become the second leading cause of death by 2020. The need to develop effective therapies has never been so pressing. Current antidepressant drugs have several limitations. This 2010 book looks at the future of mood-disorder research, covering the identification of new therapeutic targets, establishing new preclinical models, new medicinal chemistry opportunities, and fostering greater understanding of genetic influences. These strategies are likely to help build a better picture of the disease process, and lead to new opportunities for patient stratification and treatment. The ultimate goal for this strand of research is to develop more personalized and effective treatments for this chronic and debilitating condition. This is essential reading for all those involved in psychopharmacologic drug development, and mental health clinicians seeking a preview of discoveries soon to influence their practice.
Lingua: Inglese
Editore: Cambridge University Press, 2010
ISBN 10: 0521760585 ISBN 13: 9780521760584
Da: Mispah books, Redhill, SURRE, Regno Unito
EUR 302,95
Quantità: 1 disponibili
Aggiungi al carrelloHardcover. Condizione: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
Da: Brook Bookstore On Demand, Napoli, NA, Italia
EUR 137,68
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: new. Questo è un articolo print on demand.
Lingua: Inglese
Editore: Cambridge University Press, 2010
ISBN 10: 0521760585 ISBN 13: 9780521760584
Da: Revaluation Books, Exeter, Regno Unito
EUR 167,55
Quantità: 1 disponibili
Aggiungi al carrelloHardcover. Condizione: Brand New. 1st edition. 150 pages. 9.49x6.30x0.59 inches. In Stock. This item is printed on demand.
Lingua: Inglese
Editore: Cambridge University Press, Cambridge, 2010
ISBN 10: 0521760585 ISBN 13: 9780521760584
Da: Grand Eagle Retail, Bensenville, IL, U.S.A.
Hardcover. Condizione: new. Hardcover. The World Health Organization defines depression as a primary contributor to the global burden of disease and predicts it will become the second leading cause of death by 2020. The need to develop effective therapies has never been so pressing. Current antidepressant drugs have several limitations. This 2010 book looks at the future of mood-disorder research, covering the identification of new therapeutic targets, establishing new preclinical models, new medicinal chemistry opportunities, and fostering greater understanding of genetic influences. These strategies are likely to help build a better picture of the disease process, and lead to new opportunities for patient stratification and treatment. The ultimate goal for this strand of research is to develop more personalized and effective treatments for this chronic and debilitating condition. This is essential reading for all those involved in psychopharmacologic drug development, and mental health clinicians seeking a preview of discoveries soon to influence their practice. This 2010 book looks at the future of mood-disorder research, covering identification of new therapeutic targets, preclinical models, and medicinal chemistry opportunities, and increasing understanding of genetic influences. Essential reading for everyone involved in psychopharmacology development, and mental health clinicians seeking a preview of discoveries soon to influence their practice. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
Lingua: Inglese
Editore: Cambridge University Press, 2010
ISBN 10: 0521760585 ISBN 13: 9780521760584
Da: THE SAINT BOOKSTORE, Southport, Regno Unito
EUR 175,20
Quantità: Più di 20 disponibili
Aggiungi al carrelloHardback. Condizione: New. This item is printed on demand. New copy - Usually dispatched within 5-9 working days.
Lingua: Inglese
Editore: Elsevier Science Publishing Co Inc, San Diego, 2025
ISBN 10: 0443274126 ISBN 13: 9780443274121
Da: CitiRetail, Stevenage, Regno Unito
EUR 153,85
Quantità: 1 disponibili
Aggiungi al carrelloPaperback. Condizione: new. Paperback. Kratom: History, Science and Therapeutic Potential is the first book to address the unregulated, widespread availability of kratom, with its weak opioid and stimulant effects, coupled with limited awareness of it by healthcare professionals. Kratom has great therapeutic utility and medicinal potential, but more study, caution, and possible regulation is needed. It discusses geographical sourcing, historical uses, current worldwide uses, and potential for treatment of other medical conditions. Most exciting for healthcare professionals will be the implications of this substance's potential for treatment of diseases like depression, ADHD, PTSD, and substance-use disorder, particularly opioid use disorder (OUD).Moreover, kratom and its active alkaloid mitragynine are getting remarkable attention at federal and local governments as more than eight million Americans consume this product annually. Yet, the paucity of information for researchers and clinicians is troublesome. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.
Lingua: Inglese
Editore: Cambridge University Press, Cambridge, 2010
ISBN 10: 0521760585 ISBN 13: 9780521760584
Da: CitiRetail, Stevenage, Regno Unito
EUR 175,91
Quantità: 1 disponibili
Aggiungi al carrelloHardcover. Condizione: new. Hardcover. The World Health Organization defines depression as a primary contributor to the global burden of disease and predicts it will become the second leading cause of death by 2020. The need to develop effective therapies has never been so pressing. Current antidepressant drugs have several limitations. This 2010 book looks at the future of mood-disorder research, covering the identification of new therapeutic targets, establishing new preclinical models, new medicinal chemistry opportunities, and fostering greater understanding of genetic influences. These strategies are likely to help build a better picture of the disease process, and lead to new opportunities for patient stratification and treatment. The ultimate goal for this strand of research is to develop more personalized and effective treatments for this chronic and debilitating condition. This is essential reading for all those involved in psychopharmacologic drug development, and mental health clinicians seeking a preview of discoveries soon to influence their practice. This 2010 book looks at the future of mood-disorder research, covering identification of new therapeutic targets, preclinical models, and medicinal chemistry opportunities, and increasing understanding of genetic influences. Essential reading for everyone involved in psychopharmacology development, and mental health clinicians seeking a preview of discoveries soon to influence their practice. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.
Lingua: Inglese
Editore: Cambridge University Press, 2011
ISBN 10: 0521760585 ISBN 13: 9780521760584
Da: moluna, Greven, Germania
EUR 169,50
Quantità: Più di 20 disponibili
Aggiungi al carrelloGebunden. Condizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. This 2010 book looks at the future of mood-disorder research, covering identification of new therapeutic targets, preclinical models, and medicinal chemistry opportunities, and increasing understanding of genetic influences. Essential reading for everyone i.